Continence, incontinence and the aging male

Aging Male

Volumn 3, Issue 3, 2000, Pages 143-154

  Wagg, A ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Aging male; Continence; Incontinence

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

AGE; AGED; BLADDER DISEASE; CATHETERIZATION; COMMUNITY CARE; DETRUSOR DYSSYNERGIA; ENURESIS; HUMAN; MALE; POLYURIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; REVIEW; URINARY TRACT FUNCTION; URINE INCONTINENCE;

EID: 0033760320     PISSN: 13685538     EISSN: None     Source Type: Journal    
DOI: 10.1080/13685530008500326     Document Type: Review

References (81)

1. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality
2. Age and the lower urinary tract: What is normal?
3. Characterisation of detrusor contractile function in relation to old age
4. Residual urine in 75 year old men and women. A normative population study
5. Morphological and morphometric studies of the human obstructed trabeculated urinary bladder
6. Decrease in the autonomic innervation of human detrusor muscle in outflow obstruction
7. Elastin and collagen in the normal and obstructed urinary bladder
8. Detrusor in ageing and obstruction
9. The effect of age on the autonomic innervation of the urinary bladder
10. Quantitative morphometry of the adult human bladder
11. The results of prostatectomy: A symptomatic and urodynamic analysis of 152 patients
12. Standardization of terminology of lower urinary tract function
13. Bladder function in healthy volunteers: Ambulatory monitoring and conventional urodynamic studies
14. Bladder instability: Concept, clinical associations and treatment
15. Frequency volume charts: An indispensable part of lower urinary tract assessment
16. An objective comparison of the effects of parenterally administered drug in patients suffering from detrusor instability
17. Cystometric response to propantheline in detrusor hyperreflexia: Therapeutic implications
18. Effectiveness of propantheline bromide in the treatment of geriatric patients with detrusor instability
19. Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: Urodynamic evaluation. The International Study Group
20. Clinical efficacy of Oxybutynin on sensory urgency as compared with motor urgency
21. Oxybutynin chloride in the management of idiopathic detrusor instability
22. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride
23. Low dose oxybutynin for the unstable bladder
24. A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder
25. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo controlled trial
26. Controlled release oxybutynin maintains efficacy with a 43% eduction in side effects compared with conventional oxybutynin treatment
27. The pharmacokinetic properties of rectal oxybutynin - A possible alternative to intravesical administration
28. Treatment of detrusor instability with oxybutynin rectal suppositories
29. Tolterodine - A new bladder selective antimuscarinic agent
30. Anti-muscarinic potency and bladder selectivity of PNU- 200577, a major metabolite of tolterodine
31. Tolterodine, a new antimuscarinic agent: As effective but better tolerated than oxybutynin in patients with an overactive bladder
32. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity
33. The safety and clinical efficacy of two doses of tolterodine compared to placebo in elderly patients
34. Comparison of action of imipramine (Tofranil) and propantheline (Propanthine) on detrusor contraction
35. Double blind study of imipramine and placebo for incontinence due to bladder instability
36. Doxepin in the treatment of female detrusor overactivity: A randomised double blind cross over study
37. Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia - A double-blind, placebo-controlled clinical trial
38. A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence
39. Treatment of urgency and incontinence in elderly patients with propiverine hydrochloride
40. A review of flavoxate: Pharmacology and mechanism of action
41. Double blind, placebo controlled cross over study of flavoxate in the treatment of idiopathic detrusor instability
42. Flavoxate treatment of micturition disorders accompanying benign prostatic hypertrophy: A double blind, placebo controlled multi centre investigation
43. A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence
44. Double blind cross-over comparison of flavoxate and oxybutynin in women affected by urinary urge syndrome
45. Urgency incontinence
46. Behavioural versus drug treatment for urinary urge incontinence in older women. A randomized controlled trial
47. Combined behavioural and drug therapy for urge incontinence in older women
48. Special considerations in elderly individuals with urinary incontinence
49. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo controlled trial
50. Clean intermittent catheterisation in 172 adults
51. Surgery for detrusor overactivity
52. Return of erections and urinary continence following nerve sparing radical prostatectomy
53. The evaluation of 68 patients with post prostatectomy incontinence
54. Impact of anatomical radical prostatectomy on urinary incontinence
55. Urodynamic parameters to predict continence after radical prostatectomy
56. Voiding dysfunction in institutionalised elderly men: The influence of previous prostatectomy
57. The natural history of voiding dysfunction in men: The long term follow up of TURP
58. Effect of pelvic-floor re-education on duration and degree of incontinence after radical prostatectomy: A randomised controlled trial
59. Behavioural training for post prostatectomy urinary incontinence
60. Urinary incontinence after radical prostatectomy: Is professional pelvic floor training necessary
61. Transurethral polytef injection for post prostatectomy incontinence
62. Teflon injection in stress incontinence
63. Durability of the artificial sphincter in the management of urinary incontinence
64. Diurnal variation in the levels of antidiuretic hormone in the elderly
65. The use of Desmopressin (DDAVP) in nocturnal frequency in the female
66. A novel therapy for nocturnal polyuria: A double-blind randomized trial of furosemide against placebo
67. Serial incontinence assessment in elderly inpatient men
68. Oral desmopressin for nocturnal polyuria in elderly subjects: A double-blind placebo-controlled, randomized explanatory study
69. Enuresis nocturna in adults
70. The urodynamic assessment of adult enuresis
71. Urodynamic studies in enuresis and the non-neurogenic, neurogenic bladder
72. Neurophysiological measurements in primary adult enuretics
73. Oxybutynin with bladder retraining for detrusor instability in elderly people: A randomized controlled trial
74. Special considerations in elderly individuals with urinary incontinence
75. Clinical efficacy and safety of Tolterodine in the treatment of overactive bladder: A pooled analysis
76. Behavioural treatment of incontinence in the long term care setting
77. Elderly toiletting: Is two hourly too often?
78. Predictors of successful prompted voiding among incontinent nursing home residents